Overview
Pancreatitis is inflammation of the pancreas, occurring in acute (AP) and chronic (CP) forms. Acute pancreatitis ranges from mild self-limiting disease to severe necrotizing pancreatitis with 20-30% mortality. Chronic pancreatitis is a risk factor for pancreatic cancer (relative risk 2.7-16x), making the pancreatitis→PDAC progression a clinically important trajectory where microbiome interventions may have preventive value.
Microbiome Associations
Acute Pancreatitis
- Fungal dysbiosis is a feature of acute pancreatitis, with altered intestinal fungal communities detected early in the disease course zhao 2025 intestinal fungal microbiota acute pancreatitis.
- Bacterial translocation from a dysbiotic gut is a major driver of secondary pancreatic infection in severe AP sun 2023 pancreatic infections 16s rrna pancreatitis.
- 16S rRNA sequencing of pancreatic infections identifies specific bacterial communities driving infectious complications sun 2023 pancreatic infections 16s rrna pancreatitis.
Autoimmune Pancreatitis
Autoimmune pancreatitis (AIP) has a distinct fecal microbiota compared to pancreatic ductal adenocarcinoma (PDAC), despite overlapping clinical presentations. Shotgun metagenomics revealed differential functional profiles that may serve as diagnostic biomarkers zhou 2021 fecal microbiota pdac autoimmune pancreatitis metagenomics.
Causal Evidence
mendelian randomization supports a causal relationship between specific gut microbiota and pancreatitis risk wang 2023 mendelian randomization gut microbiota pancreatitis.
Interventions
Probiotics/Prebiotics/Synbiotics in Severe AP
Meta-analysis of 13 RCTs found that probiotics, prebiotics, and synbiotics reduce infectious complications in severe acute pancreatitis tian 2018 prebiotics probiotics synbiotics severe acute pancreatitis meta analysis. The mechanism likely involves:
- Strengthening gut barrier integrity to prevent bacterial translocation
- Modulating immune response to reduce pancreatic necrosis infection
- Competing with pathobionts for intestinal niches
Pancreatitis-to-Pancreatic Cancer Progression
Chronic pancreatitis is the strongest non-genetic risk factor for pancreatic cancer. The microbiome changes in CP may create a pro-tumorigenic environment through:
- Chronic inflammation via tlr4/NF-kB activation
- Altered bile acid metabolism affecting immune surveillance
- Mycobiome dysbiosis persisting through the progression
Cross-References
- pancreatic cancer — Downstream malignancy risk
- synbiotics — Meta-analysis evidence for severe AP
- mendelian randomization — Causal microbiota-pancreatitis evidence
- type 2 diabetes — Bidirectional relationship with pancreatitis
- obesity — Risk factor for AP
- tlr4 — Inflammatory cascade in pancreatitis